You just read:

VistaGen Therapeutics Appoints Pharmaceutical CNS Drug Development Executive Mark A. Smith M.D., Ph.D. as Chief Medical Officer

News provided by

VistaGen Therapeutics, Inc.

Jun 20, 2016, 08:01 ET